We are live on
!
Find out more
TD Asset Management Portfolio holdings
AUM
$115B
1-Year Est. Return
41.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.13%
1 Year Est. Return
+41.58%
3 Year Est. Return
+119.77%
5 Year Est. Return
+143.7%
10 Year Est. Return
+463.95%
AUM
$123B
AUM Growth
+$5.97B
(+5.1%)
Cap. Flow
-$2.86B
Cap. Flow
% of AUM
-2.33%
Top 10 Holdings %
Top 10 Hldgs %
27.06%
Holding
1,290
New
97
Increased
466
Reduced
615
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$671M |
| 2 |
Oracle
ORCL
|
+$306M |
| 3 |
NVIDIA
NVDA
|
+$212M |
| 4 |
Bank of Montreal
BMO
|
+$212M |
| 5 |
Cameco
CCJ
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.71B |
| 2 |
SAP
SAP
|
+$279M |
| 3 |
Visa
V
|
+$273M |
| 4 |
Eli Lilly
LLY
|
+$228M |
| 5 |
Thomson Reuters
TRI
|
+$193M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.86% |
| 2 | Financials | 22.27% |
| 3 | Industrials | 9.54% |
| 4 | Healthcare | 7.88% |
| 5 | Consumer Discretionary | 7.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CGC
1201
Canopy Growth
CGC
$426M
| $314K | ﹤0.01% |
214,967
+36,248
| +20% | +$47.1K |
|
1202
Iovance Biotherapeutics
IOVA
$2.95B
| $304K | ﹤0.01% |
139,878
| – | – |
|
1203
Horace Mann Educators
HMN
$2.1B
| $294K | ﹤0.01% |
+6,500
| New | +$286K |
|
1204
iShares MSCI India ETF
INDA
$6.58B
| $281K | ﹤0.01% |
5,391
| – | – |
|
1205
SK Telecom
SKM
$14.1B
| $279K | ﹤0.01% |
12,915
+709
| +6% | +$15.7K |
|
1206
Vanguard Morningstar Value ETF
VTV
$194B
| $273K | ﹤0.01% |
1,466
| – | – |
|
1207
Exelixis
EXEL
$12.5B
| $264K | ﹤0.01% |
+6,400
| New | +$257K |
|
1208
Dyne Therapeutics
DYN
$4.85B
| $258K | ﹤0.01% |
+20,382
| New | +$232K |
|
|
OPLN
1209
Openlane
OPLN
$4.33B
| $258K | ﹤0.01% |
+8,952
| New | +$244K |
|
1210
Omega Healthcare
OHI
$13.9B
| $253K | ﹤0.01% |
+6,000
| New | +$242K |
|
1211
Prelude Therapeutics
PRLD
$428M
| $231K | ﹤0.01% |
160,652
| – | – |
|
1212
Orchestra BioMed
OBIO
$267M
| $230K | ﹤0.01% |
92,678
| – | – |
|
1213
CAVA Group
CAVA
$8.43B
| $230K | ﹤0.01% |
+3,800
| New | +$288K |
|
1214
Equinor
EQNR
$96.3B
| $225K | ﹤0.01% |
9,210
-377
| -4% | -$9.45K |
|
1215
Entrada Therapeutics
TRDA
$290M
| $219K | ﹤0.01% |
37,788
-10,000
| -21% | -$58.5K |
|
1216
ZIM Integrated Shipping Services
ZIM
$3.23B
| $217K | ﹤0.01% |
16,000
+2,100
| +15% | +$31.9K |
|
1217
Hafnia
HAFN
$3.8B
| $208K | ﹤0.01% |
34,586
+3,859
| +13% | +$22.1K |
|
1218
Symbotic
SYM
$5.43B
| $208K | ﹤0.01% |
+3,854
| New | +$195K |
|
1219
iShares MSCI USA Min Vol Factor ETF
USMV
$24.6B
| $208K | ﹤0.01% |
2,182
-1
| -0% | -$94 |
|
1220
Cabaletta Bio
CABA
$442M
| $207K | ﹤0.01% |
88,600
| – | – |
|
1221
Voyager Therapeutics
VYGR
$198M
| $207K | ﹤0.01% |
44,350
-31,980
| -42% | -$116K |
|
1222
iShares S&P 100 ETF
OEF
$20.6B
| $204K | ﹤0.01% |
+613
| New | +$195K |
|
1223
Ginkgo Bioworks
DNA
$488M
| $190K | ﹤0.01% |
13,046
| – | – |
|
|
IAUX.WS
1224
i-80 Gold Corp Warrants
IAUX.WS
$152M
| $180K | ﹤0.01% |
+400,000
| New | +$116K |
|
|
CLYM
1225
Climb Bio
CLYM
$846M
| $180K | ﹤0.01% |
89,400
| – | – |
|
Similar funds
TD Asset Management's Q3 2025 Portfolio in Review
As of Q3 2025, TD Asset Management held 1,290 positions worth $123B, up 5.1% from $117B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
TD Asset Management's Q3 2025 filing shows 97 new, 466 increased, 615 reduced and 55 closed positions. Its largest new stake was Argan: 131,933 shares worth $35.6M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.71B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Financials and Industrials.
- TD Asset Management's largest Q3 2025 buy was Argan: 131,933 shares worth $35.6M.
- TD Asset Management added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q3 2025, an estimated $671M increase.
- TD Asset Management's biggest Q3 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.71B.
- TD Asset Management fully exited Ubiquiti in Q3 2025, selling an estimated $41.7M.
- TD Asset Management's ten largest holdings make up 27% of its $123B portfolio in Q3 2025.
- TD Asset Management opened 97 new positions and closed 55 in Q3 2025.
- TD Asset Management's portfolio value rose 5.1% quarter-over-quarter to $123B.
Based on TD Asset Management's 13F filing for Q3 2025, filed 10 Nov 2025.